Daiwa Securities Group
SLS icon

Daiwa Securities Group’s SELLAS Life Sciences SLS Stock Holding History

Daiwa Securities Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.54K Buy
+2,200
New +$9.84K ﹤0.01% 1159

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Daiwa Securities Group's SLS Position: Q1 2026 in Review

Daiwa Securities Group opened a new position in SELLAS Life Sciences (SLS) in Q1 2026: 2,200 shares worth $9.31K. The stake represents ﹤0.01% of the portfolio and ranks #1143 among its holdings.

160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Daiwa Securities Group held 2,200 shares of SELLAS Life Sciences worth $9.31K as of Q1 2026.
  • SELLAS Life Sciences was a new Daiwa Securities Group position in Q1 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Daiwa Securities Group's portfolio in Q1 2026, its #1143 holding.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.